🔻 PPLPHARMA tested the VRZ Low, where sellers attempted to push the price below the important support zone.
🚨 However, the breakdown failed to sustain as the price recovered from the lower levels.
🟢 This rejection and recovery confirmed the Breakdown Failure (BOF) setup and created a bullish intraday opportunity.
🟢 Buyers stepped in after the failed breakdown and pushed PPLPHARMA back above the key support zone.
📊 The recovery from the ₹210.50 VRZ Low showed improving buying participation.
🚀 The setup eventually delivered a strong 1.78% bullish move with an impressive 1:10 Risk-Reward.
🔴 Sellers: Attempted to extend the breakdown below the VRZ Low.
🟡 Breakdown Traders: Faced pressure as the price failed to sustain below the support zone.
🟢 Buyers: Regained control and initiated a strong bullish reversal.
🎭 The initial move below the support zone created bearish expectations.
⚠️ However, the inability to sustain below the VRZ Low weakened seller confidence.
📈 The recovery shifted market control toward buyers and supported the upside reversal.
🎯 The important confirmation came when PPLPHARMA reclaimed and sustained above the ₹210.50 VRZ Low.
🔄 The failed breakdown signaled that selling pressure was losing strength.
⚡ Continued bullish follow-through validated the BOF setup.
🔸 🚫 Failed Breakdowns Can Trap Sellers
When price fails to sustain below support and quickly recovers, bearish positions can come under pressure.
🔹 🎯 Support Reclaim Is Important
Moving back above the VRZ Low highlighted renewed buyer strength.
🛡️ Defined Risk Improves Trade Discipline
The VRZ Low provided a clear reference for managing risk.
⚡ Momentum Supports the Reversal
Once buyers regained control, the bullish move developed with strong follow-through.
📈 After reclaiming the VRZ Low, PPLPHARMA began developing a stronger intraday bullish structure.
🟢 Buyers maintained control as the price moved away from the support zone.
🚀 The improving structure supported the continuation of bullish momentum.
🔥 Buying pressure increased following the failed breakdown.
📈 Price moved strongly higher from the VRZ Low, confirming the bullish reversal.
🏆 The trade ultimately delivered a 1.78% upside move with a 1:10 RR.
🔸 The setup became actionable after PPLPHARMA failed to sustain below the ₹210.50 VRZ Low.
📈 Buyers reclaimed the support zone and maintained bullish control.
⚖️ The confirmed BOF structure provided a disciplined intraday setup with defined risk and a strong 1:10 Risk-Reward opportunity.
